Reducing Sedentary Time for Leukemia

(ReSeT in ALL Trial)

DR
BJ
Overseen ByBrittany J Van Remortel, MD, MPH
Age: < 65
Sex: Any
Trial Phase: Academic
Sponsor: Children's Hospital Los Angeles
Must be taking: Maintenance chemotherapy
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to help adolescents and young adults with acute lymphoblastic leukemia (ALL) undergoing maintenance chemotherapy reduce their sedentary time, which is time spent sitting or lying down without activity. Participants will use a fitness tracker that reminds them to move, engage in coaching sessions, and join a peer support group. These activities form part of the sedentary time intervention to determine if they encourage more activity. Researchers aim to discover whether this program not only reduces sedentary time but also improves quality of life and health markers like inflammation and metabolism. Those sitting for 4+ hours a day during leisure time and undergoing maintenance chemotherapy for ALL might find this trial suitable. As an unphased trial, this study provides a unique opportunity to contribute to innovative research that could enhance the well-being of others in similar situations.

Will I have to stop taking my current medications?

The trial does not specify whether you need to stop taking your current medications. It focuses on reducing sedentary time for those receiving maintenance chemotherapy.

What prior data suggests that this mobile health intervention is safe for adolescents and young adults with acute lymphoblastic leukemia?

Research has shown that using a fitness tracker with reminders to move is generally easy and safe. In past studies, people used these devices without major problems. For example, one study found that participants regularly walked more than 10,000 steps each week with a fitness tracker, suggesting these devices are safe and easy to use.

Additionally, other studies have used mobile health tools like apps and fitness trackers without serious side effects. These tools help people become more active and have been safely used by various groups, including those with cancer.

Overall, research indicates that using a fitness tracker with reminders to move does not pose significant safety risks. Participants in these studies usually find the devices helpful in increasing their activity levels.12345

Why are researchers excited about this trial?

Researchers are excited about the sedentary time intervention for leukemia patients because it focuses on a novel approach: reducing inactivity. Unlike traditional treatments for leukemia, which primarily involve chemotherapy, radiation, or targeted therapy, this intervention aims to improve patient outcomes by encouraging more physical activity. This method could enhance patients' overall health and quality of life, potentially reducing fatigue and improving mental well-being. By shifting focus from medication to lifestyle changes, it opens new avenues for supportive care in leukemia treatment.

What evidence suggests that this mobile health intervention is effective for reducing sedentary time in adolescents and young adults with acute lymphoblastic leukemia?

Research shows that wearable fitness trackers can help people sit less. Previous studies have indicated that these devices motivate people to move more, improving their health. One study found that fitness trackers helped children with acute lymphoblastic leukemia (ALL) become more active and feel less tired. Another review demonstrated that these trackers effectively increase physical activity and improve health in cancer patients. In this trial, participants will receive a sedentary time intervention, which includes a fitness tracker, reminders, coaching, and support from others, to help young people with ALL sit less and feel better.46789

Who Is on the Research Team?

BJ

Brittany J Ivory (Van Remortel), MD, MPH

Principal Investigator

Children's Hospital Los Angeles

Are You a Good Fit for This Trial?

This trial is for adolescents aged 12-18 with acute lymphoblastic leukemia who are sedentary, spending on average 8+ hours a day sitting or lying down. They must have completed at least one cycle of maintenance chemotherapy and be willing to reduce their sedentary time. Participants need internet access, a smartphone compatible with Fitbit and WhatsApp, and speak English fluently.

Inclusion Criteria

You spend most of your day sitting or lying down.
Are willing to spend less time sitting.
I have finished one cycle of maintenance chemotherapy and have at least one more to go.
See 4 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Intervention

Participants receive a multi-component mobile health intervention including a wearable fitness tracker, individualized coaching sessions, and an app-based peer support group to decrease sedentary time over 10 weeks.

10 weeks
In-person visits coincide with Oncology clinic visits for maintenance chemotherapy

Follow-up

Participants are monitored for changes in sedentary time, quality of life, and metabolic markers post-intervention.

2 weeks
1 visit (in-person) for final assessments

What Are the Treatments Tested in This Trial?

Interventions

  • Sedentary time intervention
Trial Overview The study tests if a mobile health intervention can decrease sedentary time in teens with ALL during maintenance chemotherapy. It includes using a fitness tracker with move reminders, coaching sessions, and an app-based support group over 10 weeks while monitoring quality of life and health changes.
How Is the Trial Designed?
1Treatment groups
Experimental Treatment
Group I: Sedentary time interventionExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Children's Hospital Los Angeles

Lead Sponsor

Trials
257
Recruited
5,075,000+

St. Baldrick's Foundation

Collaborator

Trials
19
Recruited
9,100+

Rally Foundation for Childhood Cancer Research

Collaborator

Trials
6
Recruited
500+

Published Research Related to This Trial

The study involving 86 participants found that self-reported sitting time using three different questionnaires showed weak correlations with data from thigh-worn accelerometers, indicating poor validity of self-reports.
Only about half of the participants accurately reported their sitting time, highlighting the need for sensor-based measurements to better assess sedentary behavior in future research.
Validity of Three Survey Questions for Self-Assessed Sedentary Time.Wahlström, V., Nygren, M., Olsson, D., et al.[2022]
A review of 42 studies found that hospitalized patients with acute illnesses are extremely sedentary, spending between 93% to 98.8% of their hospital stay inactive, and averaging less than 1,000 steps per day.
The study highlights the need for more research on sedentary behavior patterns in hospitalized patients, as current data primarily focuses on physical activity, with no studies reporting on sedentary bouts.
Accelerometry Shows Inpatients With Acute Medical or Surgical Conditions Spend Little Time Upright and Are Highly Sedentary: Systematic Review.Baldwin, C., van Kessel, G., Phillips, A., et al.[2022]
Survivors of childhood acute lymphoblastic leukemia (ALL) spend about 65% of their time being sedentary, which is linked to a decrease in lean body mass and an increased risk of cardiovascular disease (CVD) risk factors.
Specifically, those who are sedentary for 60% or more of the day have a significantly higher risk of developing high total cholesterol and other CVD risk factors, highlighting the importance of reducing sedentary behavior in this population.
Clinical impact of sedentary behaviors in adult survivors of acute lymphoblastic leukemia: A report from the St. Jude Lifetime Cohort study.Howell, CR., Wilson, CL., Ehrhardt, MJ., et al.[2021]

Citations

Reduce Sedentary Time in Acute Lymphoblastic LeukemiaThe goal of this feasibility trial is to test if a mobile health intervention, including a wearable fitness tracker with inactivity-triggered reminders to ...
Effect of an mHealth Intervention on Physical Activity ...Given evidence that high levels of sedentary behavior are associated with poor health outcomes in cancer survivors, future research should focus on reducing ...
Effect and feasibility of wearable physical activity trackers ...Supervised exercise interventions have been shown to be effective for increasing physical activity levels and improving health outcomes in cancer populations.
Effect of wearable activity trackers on physical activity in ...A scoping review of wearable activity monitors in interventions targeting physical activity, sedentary behavior, and sleep
Use of a Fitness Tracker to Promote Physical Activity in ...In Hooke's study, FitBit fitness tracker was used to monitoring activity and relieve the fatigue in children diagnosed with Acute Lymphoblastic Leukaemia (Hooke ...
Reduce Sedentary Time in Acute Lymphoblastic LeukemiaThe goal of this feasibility trial is to test if a mobile health intervention, including a wearable fitness tracker with inactivity-triggered reminders to ...
mHealth Interventions to Address Physical Activity and ...Overall, only four studies reported a significant decrease in SB following an mHealth intervention. Two controlled trials that used activity trackers with apps ...
Effect of an mHealth intervention on physical activity outcomes ...Current guidelines recommend that cancer survivors avoid inactivity and engage in both aerobic and resistance-based physical activity (PA) to ...
Online Physical Activity and Health Counseling for ...Advances in the medical treatment of childhood acute lymphoblastic leukemia (ALL) have resulted in 5-year survival rates above 90%- however, the success is ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security